Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis - PubMed (original) (raw)
. 2007 Sep;13(8):1004-10.
doi: 10.1177/1352458507077943. Epub 2007 Jul 10.
Affiliations
- PMID: 17623735
- DOI: 10.1177/1352458507077943
Cognitive dysfunction in patients with clinically isolated syndromes or newly diagnosed multiple sclerosis
B I Glanz et al. Mult Scler. 2007 Sep.
Abstract
Cognitive dysfunction is common in patients with multiple sclerosis (MS), and has been associated with MRI measures of lesion burden and atrophy. Little is known about the prevalence of cognitive impairment in patients with early MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course are also unclear. This study used a brief battery of cognitive tests to determine the prevalence and pattern of cognitive impairment in patients with clinically isolated syndromes or newly diagnosed MS. The associations between cognitive impairment and MRI measures of disease severity early in the disease course were also examined. Ninety-two patients with clinically isolated syndromes or the diagnosis of MS within the last 3 years participating in the CLIMB study underwent a neurologic examination, neuropsychological evaluation and MRI at 1.5 T. Forty-nine percent of patients were impaired on one or more cognitive measures. There were no significant correlations between cognitive scores and MRI measures of disease severity including total T2 lesion volume, normal appearing white matter volume, grey matter volume, and brain parenchymal fraction. These findings suggest that cognitive impairment may predate the appearance of gross structural abnormalities on MRI and serve as an early marker of disease activity in MS.
Similar articles
- Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G; COGIMUS Study Group. Patti F, et al. Mult Scler. 2009 Jul;15(7):779-88. doi: 10.1177/1352458509105544. Mult Scler. 2009. PMID: 19542262 - Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden.
Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Benedict RH, et al. Arch Neurol. 2004 Feb;61(2):226-30. doi: 10.1001/archneur.61.2.226. Arch Neurol. 2004. PMID: 14967771 Clinical Trial. - Brain volumetry counterparts of cognitive impairment in patients with multiple sclerosis.
Sastre-Garriga J, Arévalo MJ, Renom M, Alonso J, González I, Galán I, Montalban X, Rovira A. Sastre-Garriga J, et al. J Neurol Sci. 2009 Jul 15;282(1-2):120-4. doi: 10.1016/j.jns.2008.12.019. Epub 2009 Jan 21. J Neurol Sci. 2009. PMID: 19157420 - Correlating brain atrophy with cognitive dysfunction, mood disturbances, and personality disorder in multiple sclerosis.
Benedict RH, Carone DA, Bakshi R. Benedict RH, et al. J Neuroimaging. 2004 Jul;14(3 Suppl):36S-45S. doi: 10.1177/1051228404266267. J Neuroimaging. 2004. PMID: 15228758 Review. - [Cognitive impairment].
Reuter F, Audoin B, Rico A, Malikova I, Ranjeva JP, Pelletier J. Reuter F, et al. Rev Neurol (Paris). 2009 Mar;165 Suppl 4:S113-22. doi: 10.1016/S0035-3787(09)72122-8. Rev Neurol (Paris). 2009. PMID: 19361675 Review. French.
Cited by
- Behavioral disorders in multiple sclerosis: a comprehensive review.
Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2024 Sep 4. doi: 10.1007/s00702-024-02816-9. Online ahead of print. J Neural Transm (Vienna). 2024. PMID: 39231817 Review. - Association Between Disease-Modifying Therapy and Information Processing Speed in Multiple Sclerosis.
Aboseif A, Amin M, Bena J, Nakamura K, Macaron G, Ontaneda D. Aboseif A, et al. Int J MS Care. 2024 May-Jun;26(3):91-97. doi: 10.7224/1537-2073.2023-010. Epub 2024 May 16. Int J MS Care. 2024. PMID: 38765300 Free PMC article. - The 7-year follow-up of the Hungarian BICAMS validation cohort implies that cognitive performance may improve in multiple sclerosis patients.
Nyári A, Kokas Z, Szamosi S, Fricska-Nagy Z, Füvesi J, Kincses ZT, Biernacki T, Vécsei L, Klivényi P, Bencsik K, Sandi D. Nyári A, et al. Neurol Sci. 2024 Jul;45(7):3369-3378. doi: 10.1007/s10072-024-07347-5. Epub 2024 Jan 27. Neurol Sci. 2024. PMID: 38280085 - Association of cognitive impairment and quality of life in patients with multiple sclerosis: A cross-sectional study.
Nabizadeh F, Balabandian M, Rostami MR, Owji M, Sahraian MA, Bidadian M, Ghadiri F, Rezaeimanesh N, Moghadasi AN. Nabizadeh F, et al. Curr J Neurol. 2022 Jul 6;21(3):144-150. doi: 10.18502/cjn.v21i3.11106. Curr J Neurol. 2022. PMID: 38011341 Free PMC article. - Functional and structural brain MRI changes associated with cognitive worsening in multiple sclerosis: a 3-year longitudinal study.
Azzimonti M, Preziosa P, Pagani E, Valsasina P, Tedone N, Vizzino C, Rocca MA, Filippi M. Azzimonti M, et al. J Neurol. 2023 Sep;270(9):4296-4308. doi: 10.1007/s00415-023-11778-z. Epub 2023 May 18. J Neurol. 2023. PMID: 37202603
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical